Degradation-resistant glucocorticosteroid formulations

Details for Australian Patent Application No. 2002245329 (hide)

Owner IVAX LABORATORIES

Inventors Zhang, Kai; Buenafe, Mina; Brucato, Michael

Agent Griffith Hack

Pub. Number AU-A-2002245329

PCT Pub. Number WO2002/058705

Priority 09/768,915 24.01.01 US

Filing date 24 January 2002

Wipo publication date 6 August 2002

International Classifications

A61K 031/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 031/355

A61K 031/375 - Ascorbic acid, i.e. vitamin C

A61K 009/00 Medicinal preparations characterised by special physical form

A61P 011/00 Drugs for disorders of the respiratory system

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002245329

14 August 2003 Change of Name(s) of Applicant(s), Section 104

  Ivax Laboratories The name of the applicant has been changed to IVAX Research, Inc.

10 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245330-INHIBITION OF PROTEASOMES TO PREVENT RESTENOSIS

2002245328-PHASE CHANGE COMPOSITION CONTAINING A NUCLEATING AGENT